GLPwatch
Managing Adverse Effects of Incretin-Based Medications for Obesity.
JAMA · 2025
Last updated 2026-09-22| Journal | JAMA, 2025 |
|---|---|
| Citations | 23 |
| Relative citation ratio | 6.17 |
| Molecules | — |
| Conditions studied | Obesity |
Full record and abstract on PubMed 40728833 ↗
JAMA · 2025
Last updated 2026-09-22| Journal | JAMA, 2025 |
|---|---|
| Citations | 23 |
| Relative citation ratio | 6.17 |
| Molecules | — |
| Conditions studied | Obesity |
Full record and abstract on PubMed 40728833 ↗